Works matching AU Ascher-Svanum, Haya

Results: 58

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial.

Published in:

BMC Medical Research Methodology, 2012, v. 12, n. 1, p. 142, doi. 10.1186/1471-2288-12-142

By:

Faries, Douglas;
Ascher-Svanum, Haya;
Phillips, Glenn;
Nyhuis, Allen W.;
Sugihara, Tomoko;
Stauffer, Virginia;
Kinon, Bruce J.

Publication type:

Article

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.

Published in:

International Journal of General Medicine, 2012, v. 5, p. 391, doi. 10.2147/IJGM.S29052

By:

Ascher-Svanum, Haya;
Montgomery, William S.;
McDonnell, David P.;
Coleman, Kristina A.;
Feldman, Peter D.

Publication type:

Article

Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia.

Published in:

BMC Research Notes, 2009, v. 2, p. 1, doi. 10.1186/1756-0500-2-6

By:

Ascher-Svanum, Haya;
Zhu, Baojin;
Faries, Douglas E.;
Furiak, Nicolas M.;
Montgomery, William

Publication type:

Article

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan.

Published in:

Psychiatry & Clinical Neurosciences, 2012, v. 66, n. 4, p. 313, doi. 10.1111/j.1440-1819.2012.02351.x

By:

Ye, Wenyu;
Fujikoshi, Shinji;
Nakahara, Naohiro;
Takahashi, Michihiro;
Ascher‐Svanum, Haya;
Ohmori, Tetsuro

Publication type:

Article

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia.

Published in:

Schizophrenia Bulletin, 2008, v. 34, n. 6, p. 1163, doi. 10.1093/schbul/sbm134

By:

Ascher-Svanum, Haya;
Nyhuis, Allen W.;
Faries, Douglas E.;
Kinon, Bruce J.;
Baker, Robert W.;
Shekhar, Anantha

Publication type:

Article

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone.

Published in:

Schizophrenia Bulletin, 2007, v. 33, n. 6, p. 1379

By:

Olfson, Mark;
Marcus, Steven C.;
Ascher-Svanum, Haya

Publication type:

Article

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Published in:

Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 1287, doi. 10.2147/NDT.S60246

By:

Montgomery, William;
Treuer, Tamas;
Wenyu Ye;
Hai Bo Xue;
Sheng Hu Wu;
Li Liu;
Kadziola, Zbigniew;
Stensland, Michael D.;
Ascher-Svanum, Haya

Publication type:

Article

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection.

Published in:

Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 1125, doi. 10.2147/NDT.S61409

By:

Ascher-Svanum, Haya;
Novick, Diego;
Haro, Josep Maria;
Bertsch, Jordan;
McDonnell, David;
Detke, Holland

Publication type:

Article

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia.

Published in:

Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 815, doi. 10.2147/NDT.S43574

By:

Lei Chen;
Ascher-Svanum, Haya;
Lawson, Anthony;
Stauffer, Virginia L.;
Nyhuis, Allen;
Haynes, Virginia;
Schuh, Kory;
Kinon, Bruce J.

Publication type:

Article

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia.

Published in:

Neuropsychiatric Disease & Treatment, 2012, v. 8, p. 113, doi. 10.2147/NDT.S30268

By:

Ascher-Svanum, Haya;
Brnabic, Alan J. M.;
Lawson, Anthony H.;
Kinon, Bruce J.;
Stauffer, Virginia L.;
Feldman, Peter D.;
Kelin, Katarina

Publication type:

Article

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.

Published in:

Neuropsychiatric Disease & Treatment, 2012, v. 8, p. 259, doi. 10.2147/NDT.S25662

By:

Wenyu Ye;
Ascher-Svanum, Haya;
Tanji, Yuka;
Flynn, Jennifer A.;
Takahashi, Michihiro;
Conley, Robert R.

Publication type:

Article

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial.

Published in:

BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-320

By:

Lei Chen;
Johnston, Joseph A.;
Kinon, Bruce J.;
Stauffer, Virginia;
Succop, Paul;
Marques, Tiago R.;
Ascher-Svanum, Haya

Publication type:

Article

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.

Published in:

BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-224

By:

Ascher-Svanum, Haya;
Novick, Diego;
Haro, Josep Maria;
Bertsch, Jordan;
McDonnell, David;
Detke, Holland

Publication type:

Article

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.

Published in:

BMC Psychiatry, 2012, v. 12, n. 1, p. 222, doi. 10.1186/1471-244X-12-222

By:

Haynes, Virginia S;
Baojin Zhu;
Stauffer, Virginia L;
Kinon, Bruce J;
Stensland, Michael D;
Lei Xu;
Ascher-Svanum, Haya

Publication type:

Article

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.

Published in:

BMC Psychiatry, 2011, v. 11, n. 1, p. 87, doi. 10.1186/1471-244X-11-87

By:

Hong Liu-Seifert;
Ascher-Svanum, Haya;
Osuntokun, Olawale;
Kai Yu Jen;
Gomez, Juan Carlos

Publication type:

Article

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.

Published in:

BMC Psychiatry, 2011, v. 11, n. 1, p. 23, doi. 10.1186/1471-244X-11-23

By:

Ruberg, Stephen J.;
Lei Chen;
Stauffer, Virginia;
Ascher-Svanum, Haya;
Kollack-Walker, Sara;
Conley, Robert R.;
Kane, John;
Kinon, Bruce J.

Publication type:

Article

Predictors of switching antipsychotic medications in the treatment of schizophrenia.

Published in:

BMC Psychiatry, 2010, v. 10, p. 75, doi. 10.1186/1471-244X-10-75

By:

Nyhuis, Allen W.;
Faries, Douglas E.;
Ascher-Svanum, Haya;
Stauffer, Virginia L.;
Kinon, Bruce J.

Publication type:

Article

The cost of relapse and the predictors of relapse in the treatment of schizophrenia.

Published in:

BMC Psychiatry, 2010, v. 10, p. 1, doi. 10.1186/1471-244X-10-2

By:

Ascher-Svanum, Haya;
Baojin Zhu;
Faries, Douglas E.;
Salkever, David;
Slade, Eric P.;
Xiaomei Peng;
Conley, Robert R.

Publication type:

Article

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia.

Published in:

BMC Psychiatry, 2010, v. 10, p. 11, doi. 10.1186/1471-244X-10-11

By:

Ascher-Svanum, Haya;
Nyhuis, Allen W.;
Faries, Douglas E.;
Ball, Daniel E.;
Kinon, Bruce J.

Publication type:

Article

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.

Published in:

BMC Psychiatry, 2009, v. 9, p. 1, doi. 10.1186/1471-244X-9-13

By:

Stauffer, Virginia;
Ascher-Svanum, Haya;
Lin Liu;
Ball, Tamara;
Conley, Robert

Publication type:

Article

Costs of treating patients with schizophrenia who have illness-related crisis events.

Published in:

BMC Psychiatry, 2008, v. 8, p. 1

By:

Baojin Zhu;
Ascher-Svanum, Haya;
Faries, Douglas E.;
Xiaomei Peng;
Salkever, David;
Slade, Eric P.

Publication type:

Article

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

Published in:

BMC Psychiatry, 2008, v. 8, p. 1, doi. 10.1186/1471-244X-8-19

By:

Zhu, Baojin;
Ascher-Svanum, Haya;
Faries, Douglas E.;
Correll, Christoph U.;
Kane, John M.

Publication type:

Article

Item response analysis of the Positive and Negative Syndrome Scale.

Published in:

BMC Psychiatry, 2007, v. 7, p. 66, doi. 10.1186/1471-244X-7-66

By:

Santor, Darcy A.;
Ascher-Svanum, Haya;
Lindenmayer, Jean-Pierre;
Obenchain, Robert L.

Publication type:

Article

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.

Published in:

BMC Psychiatry, 2006, v. 6, p. 8, doi. 10.1186/1471-244X-6-8

By:

Ascher-Svanum, Haya;
Baojin Zhu;
Faries, Douglas;
Landbloom, Ron;
Swartz, Marvin;
Swanson, Jeff

Publication type:

Article

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.

Published in:

BMC Psychiatry, 2005, v. 5, p. 26, doi. 10.1186/1471-244X-5-26

By:

Faries, Douglas;
Ascher-Svanum, Haya;
Baojin Zhu;
Correll, Christoph;
Kane, John

Publication type:

Article

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.

Published in:

BMC Psychiatry, 2005, v. 5, p. 3, doi. 10.1186/1471-244X-5-3

By:

Ascher-Svanum, Haya;
Stensland, Michael;
Zhongyun Zhao;
Kinon, Bruce J.

Publication type:

Article

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia.

Published in:

Neuropsychopharmacology, 2010, v. 35, n. 2, p. 581, doi. 10.1038/npp.2009.164

By:

Kinon, Bruce J.;
Lei Chen;
Ascher-Svanum, Haya;
Stauffer, Virginia L.;
Kollack-Walker, Sara;
Wei Zhou;
Kapur, Shitij;
Kane, John M.

Publication type:

Article

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.

Published in:

ClinicoEconomics & Outcomes Research, 2013, v. 5, p. 407, doi. 10.2147/CEOR.S44325

By:

Montgomery, William;
Li Liu;
Stensland, Michael D.;
Hai Bo Xue;
Treuer, Tamas;
Ascher-Svanum, Haya

Publication type:

Article

Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.

Published in:

Diabetes Therapy, 2015, v. 6, n. 4, p. 651, doi. 10.1007/s13300-015-0132-0

By:

Fu, Haoda;
Cao, Dachuang;
Boye, Kristina;
Curtis, Bradley;
Schuster, Dara;
Kendall, David;
Ascher-Svanum, Haya

Publication type:

Article

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.

Published in:

Diabetes Therapy, 2015, v. 6, n. 3, p. 317, doi. 10.1007/s13300-015-0119-x

By:

Fu, Haoda;
Cao, Dachuang;
Boye, Kristina;
Curtis, Bradley;
Schuster, Dara;
Kendall, David;
Ascher-Svanum, Haya

Publication type:

Article

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.

Published in:

Diabetes Therapy, 2015, v. 6, n. 3, p. 303, doi. 10.1007/s13300-015-0118-y

By:

Ascher-Svanum, Haya;
Zagar, Anthony;
Jiang, Dingfeng;
Schuster, Dara;
Schmitt, Henry;
Dennehy, Ellen;
Kendall, David;
Raskin, Joel;
Heine, Robert

Publication type:

Article

Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.

Published in:

Diabetes Therapy, 2015, v. 6, n. 3, p. 403, doi. 10.1007/s13300-015-0124-0

By:

Ascher-Svanum, Haya;
Zagar, Anthony;
Jiang, Dingfeng;
Schuster, Dara;
Schmitt, Henry;
Dennehy, Ellen;
Kendall, David;
Raskin, Joel;
Heine, Robert

Publication type:

Article

Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus.

Published in:

Diabetes Therapy, 2014, v. 5, n. 1, p. 225, doi. 10.1007/s13300-014-0065-z

By:

Ascher-Svanum, Haya;
Lage, Maureen;
Perez-Nieves, Magaly;
Reaney, Matthew;
Lorraine, Joanne;
Rodriguez, Angel;
Treglia, Michael

Publication type:

Article

One-year outcomes in schizophrenia after switching from typical antipsychotic to olanzapine in Japan: an observational study.

Published in:

Pragmatic & Observational Research, 2012, v. 3, p. 41

By:

Wenyu Ye;
Fujikoshi, Shinji;
Nakahara, Naohiro;
Takahashi, Michihiro;
Ascher-Svanum, Haya;
Ohmori, Tetsuro

Publication type:

Article

Schizophrenia Outpatient Health Outcomes study: twelve-month findings.

Published in:

Pragmatic & Observational Research, 2012, v. 3, p. 27, doi. 10.2147/por.s26552

By:

Novick, Diego;
Ascher-Svanum, Haya;
Haro, Josep Maria;
Bertsch, Jordan;
Takahashi, Michihiro

Publication type:

Article

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.

Published in:

2016

By:

Lebrec, Jeremie;
Ascher-Svanum, Haya;
Yun-Fei Chen;
Reed, Catherine;
Kahle-Wrobleski, Kristin;
Hake, Ann Marie;
Raskin, Joel;
Naderali, Ebrahim;
Schuster, Dara;
Heine, Robert J.;
Kendall, David M.;
Chen, Yun-Fei

Publication type:

journal article

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia.

Published in:

2012

By:

Witte MM;
Case MG;
Schuh KJ;
Ascher-Svanum H;
Witte, Michael M;
Case, Michael G;
Schuh, Kory J;
Ascher-Svanum, Haya

Publication type:

journal article

Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model.

Published in:

Current Medical Research & Opinion, 2011, v. 27, n. 4, p. 713, doi. 10.1185/03007995.2011.554533

By:

Nicolas M. Furiak;
Haya Ascher-Svanum;
Robert W. Klein;
Lee J. Smolen;
Anthony H. Lawson;
William Montgomery;
Robert R. Conley

Publication type:

Article

Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 10, p. 2403, doi. 10.1185/03007995.2010.515900

By:

Haya Ascher-Svanum;
Allen W. Nyhuis;
Virginia Stauffer;
Bruce J. Kinon;
Douglas E. Faries;
Glenn A. Phillips;
Kory Schuh;
A. George Awad;
Richard Keefe;
Dieter Naber

Publication type:

Article

Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 10, p. 2499, doi. 10.1185/03007995.2010.519278

By:

Lizheng Shi;
Yingnan Zhao;
Vivian Fonseca;
Haya Ascher-Svanum;
Yi-Ju Chiang;
Daniel Winstead

Publication type:

Article

Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia.

Published in:

Current Medical Research & Opinion, 2008, v. 24, n. 5, p. 1399, doi. 10.1185/030079908X297385

By:

Douglas E. Faries;
Haya Ascher-Svanum;
Allen W. Nyhuis;
Bruce J. Kinon

Publication type:

Article

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Published in:

2007

By:

Zhu B;
Kulkarni PM;
Stensland MD;
Ascher-Svanum H;
Zhu, Baojin;
Kulkarni, Pandurang M;
Stensland, Michael D;
Ascher-Svanum, Haya

Publication type:

journal article

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 11, p. 2805, doi. 10.1185/030079907X233322

By:

Baojin Zhu;
Pandurang M Kulkarni;
Michael D. Stensland;
Haya Ascher-Svanum

Publication type:

Article

Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools.

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 10, p. 2551, doi. 10.1185/030079907X233269

By:

Jamie Karagianis;
Michael Rosenbluth;
Mauricio Tohen;
Haya Ascher-Svanum;
Tamas Treuer;
Mauricio Silva de Lima;
Leslie Citrome

Publication type:

Article

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties.

Published in:

Patient Preference & Adherence, 2012, v. 6, p. 109, doi. 10.2147/PPA.S27344

By:

Montgomery, William;
Treuer, Tamas;
Karagianis, Jamie;
Ascher-Svanum, Haya;
Harrison, Gavan

Publication type:

Article

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.

Published in:

Patient Preference & Adherence, 2012, v. 6, p. 521, doi. 10.2147/PPA.S25635

By:

Matza, Louis S.;
Phillips, Glenn A.;
Revicki, Dennis A.;
Ascher-Svanum, Haya;
Malley, Karen G.;
Palsgrove, Andrew C.;
Faries, Douglas E.;
Stauffer, Virginia;
Kinon, Bruce J.;
George Awad, A.;
Keefe, Richard S.E.;
Naber, Dieter

Publication type:

Article

Analysis of Treatment Effectiveness in Longitudinal Observational Data.

Published in:

Journal of Biopharmaceutical Statistics, 2007, v. 17, n. 5, p. 809, doi. 10.1080/10543400701513967

By:

Faries, Douglas;
Ascher-Svanum, Haya;
Belger, Mark

Publication type:

Article

Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.

Published in:

2013

By:

Ascher-Svanum, Haya;
Novick, Diego;
Haro, Josep Maria;
Aguado, Jaume;
Cui, Zhanglin

Publication type:

journal article

Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia.

Published in:

Quality of Life Research, 2013, v. 22, n. 8, p. 2085, doi. 10.1007/s11136-012-0335-z

By:

Ascher-Svanum, Haya;
Novick, Diego;
Haro, Josep Maria;
Aguado, Jaume;
Cui, Zhanglin

Publication type:

Article

Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.

Published in:

2004

By:

Tunis, Sandra L.;
Ascher-Svanum, Haya;
Stensland, Michael;
Kinon, Bruce L;
Kinon, Bruce J

Publication type:

journal article